Emergex Vaccines raised €9.9M in a Series A round in Sep 2020. The company is based in Abingdon, UK. Investors in the round: Vickers Venture Partners. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €9.9M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.